Impact on grafted kidney function of rocuronium-sugammadex vs cisatracurium-neostigmine strategy for neuromuscular block management. An Italian single-center, 2014-2017 retrospective cohort case-control study

BACKGROUND: The impact of sugammadex in patients with end-stage renal disease undergoing kidney transplantation is still far from being defined. The aim of the study is to compare sugammadex to neostigmine for reversal of rocuronium- and cisatracurium-induced neuromuscular block (NMB), respectively,...

Descripción completa

Detalles Bibliográficos
Autores principales: Carron, M., Andreatta, G., Pesenti, E., De Cassai, A., Feltracco, P., Linassi, F., Sergi, M., Di Bella, C., Di Bello, M., Neri, F., Silvestre, C., Furian, L., Navalesi, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756660/
https://www.ncbi.nlm.nih.gov/pubmed/35022076
http://dx.doi.org/10.1186/s13741-021-00231-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756660/
https://www.ncbi.nlm.nih.gov/pubmed/35022076
http://dx.doi.org/10.1186/s13741-021-00231-2

Ejemplares similares